Børge Sørvoll
Patrimonio netto: 207 544 $ in data 31/07/2026
Patrimonio netto: 207 544 $ in data 31/07/2026
Børge Sørvoll currently works at Biotec BetaGlucans AS, as Chairman and ArcticZymes Technologies ASA, as Chief Financial Officer from 2014.
Mr. Sørvoll also formerly worked at Troms Kraft Invest AS, as Managing Director & Chief Financial Officer, Front Exploration AS, as Chief Financial Officer, and Subsea 7 Norway AS, as Manager.
Mr. Sørvoll received his undergraduate degree from the University of Wyoming.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2024 | 100.428 ( 0,2% ) | 207 544 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Direttore Finanziario/CFO | 01/10/2014 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Direttore Finanziario/CFO | - |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Corporate Officer/Principal | - |
Troms Kraft Invest AS | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Commercial Services |
Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale